Anthony Feinstein: Improving Treatment and Education of Depression and Cognition in Multiple Sclerosis

Video

There is still much more to be learned about the effects of depression and cognitive impairment in patients with multiple sclerosis but there are steps being taken to address these issues and help better inform patients of the impact both can play in their lives.

There is still much more to be learned about the effects of depression and cognitive impairment in patients with multiple sclerosis but there are steps being taken to address these issues and help better inform patients of the impact both can play in their lives.

Working at the University of Toronto Anthony Feinstein, MD, PhD, has been working on learning more about both of these areas but said there is much more work to be done as his research continues. Speaking at the annual meeting of the Consortium of Multiple Sclerosis Centers Feinstein said it is important for doctors to have what can be a difficult discussion with their patients about these issues to help them prepare for what could potentially be in their future.

Related Videos
Elizabeth Cerceo, MD | Credit: ACP
Insight on the Promising 52-Week KarXT Data with Rishi Kakar, MD
Sunny Rai, PhD: “I” Language Markers Do Not Detect Depression in Black Individuals
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
© 2024 MJH Life Sciences

All rights reserved.